|
⚲
|
| Keyboard |
| BioDiscovery 4 FCPR
✚
|
|
|---|---|
| CIK # | 0001756321 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001756321] | |
| 4 | [0001756321] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| BioDiscovery 4 FCPR | |
| Andera Partners | |
| Axonics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Axonics Inc AXNX
Common Stock
|
2020-01-22 | Sell | 135,261 | $31.54 | 4,266,132 |
|
Axonics Inc AXNX
Common Stock
|
2020-01-17 | Sell | 164,739 | $31.51 | 5,190,926 |
|
Axonics Inc AXNX
Common Stock
|
2019-11-22 | Sell | 300,000 | $20.74 | 6,222,000 |
|
Axonics Inc AXNX
Common Stock
|
2018-11-02 | Conversion | 431,250 | ||
|
Axonics Inc AXNX
Common Stock
|
2018-11-02 | Conversion | 654,237 | ||
|
Axonics Inc AXNX
Series C Preferred Stock · derivative
|
2018-11-02 | Conversion | 545,197 | $0.00 | |
|
Axonics Inc AXNX
Common Stock
|
2018-11-02 | Conversion | 806,080 | ||
|
Axonics Inc AXNX
Series A Preferred Stock · derivative
|
2018-11-02 | Conversion | 345,000 | $0.00 | |
|
Axonics Inc AXNX
Series B-1 Preferred Stock · derivative
|
2018-11-02 | Conversion | 671,733 | $0.00 | |
|
Axonics Inc AXNX
Series B-2 Preferred Stock · derivative
|
2018-11-02 | Conversion | 359,375 | $0.00 | |
|
Axonics Inc AXNX
Common Stock
|
2018-11-02 | Conversion | 799,228 | ||
|
Axonics Inc AXNX
Common Stock
|
2018-11-02 | Buy | 866,666 | $15.00 | 12,999,990 |